Gastric adenocarcinoma

Papers on gastric adenocarcinoma

35 papers2 new in 30 days

Tuesday, November 3

Wednesday, October 28

Saturday, October 17

Wednesday, October 14

Monday, October 5

Tuesday, August 18

Thursday, July 30

Thursday, July 16

Thursday, July 2

Sunday, May 31

Sunday, May 3

Monday, March 16

Monday, March 9

Cancer Prevention Research

Eflornithine may lower a DNA damage marker in stomach lesions

Between months 18 and 24, after treatment ended, DNA damage marker scores fell 18.3 points with eflornithine versus 1.6 with placebo.Between months 18 and 24, after treatment ended, DNA damage marker scores fell 18.3 points with eflornithine versus 1.6 with placebo.

Randomized trial · 55 peopleInterventions

Thursday, March 5

Monday, January 12

Tuesday, December 9

Thursday, August 28

Friday, June 20

Monday, April 28

Thursday, February 13

Saturday, January 25

Thursday, October 3

Wednesday, September 4

Thursday, May 23

Tuesday, October 31

Monday, July 10

Friday, March 18

Wednesday, February 23

Tuesday, December 1